TY - JOUR
T1 - A case-control study for multidrug-resistant tuberculosis
T2 - Risk factors in four European countries
AU - Casal, Manuel
AU - Vaquero, M.
AU - Rinder, H.
AU - Tortoli, E.
AU - Grosset, J.
AU - Rüsch-Gerdes, S.
AU - Gutiérrez, J.
AU - Jarlier, V.
PY - 2005/3
Y1 - 2005/3
N2 - The aim of this study was to detect risk factors for multidrug resistance in patients with pulmonary tuberculosis in four European Union countries: France, Germany, Italy, and Spain. A prospective epidemiological case control study was conducted, made up of patients with clinically diagnosed and microbiologically confirmed pulmonary tuberculosis in the four countries between 1997 and 2000. A total of 138 cases and 276 contols were studied. Considering the four countries as a whole, the most statistically significant risk factors were as follows: intravenous drug use (OR 4.68); asylum-seeker support (OR 2.55) as income factor; living in a nursing home (OR 2.05); previous tuberculosis (OR 2.03) with pulmonary location; prison (OR 2.02); known tuberculosis contacts (OR 2.01); immunosuppression other than human immunodeficiency virus (HIV) (OR 1.96); acquired immunodeficiency syndrome (AIDS) (OR 1.96); current tuberculosis with pulmonary location (OR 1.77); and health-care worker (OR 1.69). These risk factors will have to be taken into account in the European Union as a whole, as well as in each individual country, to establish a health policy of monitoring and control for these cases of multidrug resistance. Although rare, their seriousness makes them particularly important.
AB - The aim of this study was to detect risk factors for multidrug resistance in patients with pulmonary tuberculosis in four European Union countries: France, Germany, Italy, and Spain. A prospective epidemiological case control study was conducted, made up of patients with clinically diagnosed and microbiologically confirmed pulmonary tuberculosis in the four countries between 1997 and 2000. A total of 138 cases and 276 contols were studied. Considering the four countries as a whole, the most statistically significant risk factors were as follows: intravenous drug use (OR 4.68); asylum-seeker support (OR 2.55) as income factor; living in a nursing home (OR 2.05); previous tuberculosis (OR 2.03) with pulmonary location; prison (OR 2.02); known tuberculosis contacts (OR 2.01); immunosuppression other than human immunodeficiency virus (HIV) (OR 1.96); acquired immunodeficiency syndrome (AIDS) (OR 1.96); current tuberculosis with pulmonary location (OR 1.77); and health-care worker (OR 1.69). These risk factors will have to be taken into account in the European Union as a whole, as well as in each individual country, to establish a health policy of monitoring and control for these cases of multidrug resistance. Although rare, their seriousness makes them particularly important.
UR - http://www.scopus.com/inward/record.url?scp=14944341222&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=14944341222&partnerID=8YFLogxK
U2 - 10.1089/mdr.2005.11.62
DO - 10.1089/mdr.2005.11.62
M3 - Article
C2 - 15770097
AN - SCOPUS:14944341222
SN - 1076-6294
VL - 11
SP - 62
EP - 67
JO - Microbial Drug Resistance
JF - Microbial Drug Resistance
IS - 1
ER -